Subscribe: Biotechnology
http://rss.prnewswire.com/industry/bio
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced  april prnewswire  april  company  liver  market  new  prnewswire  research markets  research  study  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology



Press Releases from PR Newswire about Biotechnology



Published: Mon, 24 Apr 2017 05:29:02 EDT

Last Build Date: Mon, 24 Apr 2017 03:07:00 EDT

 



Update on the Development of Simeprevir as Part of the Triple Combination With AL-335 and Odalasvir (JNJ-4178)

Mon, 24 Apr 2017 03:07:00 EDT

(image) STOCKHOLM, April 24, 2017 /PRNewswire/ --Medivir AB (Nasdaq Stockholm: MVIR) today communicates an update on the status of the development of JNJ-4178, the triple combination of simeprevir, odalasvir and AL-335, following The International Liver Congress™ 2017 of the European Association...



Media Files:
http://www.clinicaltrials.gov




Dante Labs Offers EUR 850 Whole Genome Sequencing and Interpretation for the First Time in the World

Mon, 24 Apr 2017 03:00:00 EDT

(image) NEW YORK, April 24, 2017 /PRNewswire/ -- Dante Labs announced today the offer of whole genome sequencing (WGS) and interpretation at only EUR 850 (ca. $900). While American individuals have been able to access WGS at $1,000, this innovation marks the first time Europeans can access WGS...



Media Files:
https://mma.prnewswire.com/media/493134/Dante_Labs_EUR_850_Whole_Genome_Sequencing.jpg




Shire Launches #PIPostsThanks Social Campaign to Raise Awareness of Primary Immunodeficiency (PI)

Mon, 24 Apr 2017 01:00:00 EDT

ZUG, Switzerland, April 24, 2017 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, is launching #PIPostsThanks, a social campaign to spotlight the unsung heroes who make a difference in the lives of people living with primary immunodeficiency...



NGM Bio Announces NGM282 Dramatically Reduced Liver Fat and Other Biomarkers Associated With Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial

Sat, 22 Apr 2017 10:00:00 EDT

(image) AMSTERDAM, April 22, 2017 /PRNewswire/ -- NGM Bio announced that its lead product candidate, NGM282, met the primary endpoint and key secondary endpoints in a Phase 2 trial of patients with nonalcoholic steatohepatitis (NASH). NGM282, which is a non-tumorigenic, engineered variant of the...



Media Files:
https://mma.prnewswire.com/media/486671/NGM_Bio_Logo.jpg




Tangential Flow Filtration Market to Grow at a CAGR of 12.6% by 2021: Stringent Government Regulations for Validation of Filtration Processes is Restraining Market Growth - Research and Markets

Fri, 21 Apr 2017 19:30:00 EDT

(image) DUBLIN, Apr. 21, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Tangential Flow Filtration Market - Global Forecast to 2021" report to their offering. The tangential flow filtration market is projected to reach USD 1,005.0 million by 2021 USD 554.7...



Media Files:
http://photos.prnewswire.com/prnvar/20160330/349511LOGO




Dr. Eric Lawitz, of the Texas Liver Institute, Presents Groundbreaking Research in Nonalcoholic Steatohepatitis (NASH) at the International Liver Congress™ 2017

Fri, 21 Apr 2017 18:31:00 EDT

(image) SAN ANTONIO, April 21, 2017 /PRNewswire/ -- Dr. Eric Lawitz, internationally recognized for his work in liver disease, presented a proof-of-concept study at The International Liver Congress™ 2017, presented by the European Association for the Study of Liver (EASL). The study was performed...



Media Files:
http://www.txliver.com




20 Year Old Kibow Biotech Further Validates Enteric Dialysis® Concept, With Greater Understanding of Modulating the Gut Microbiome with Pro/Prebiotics Towards Maintaining Healthy Kidney Function

Fri, 21 Apr 2017 15:04:00 EDT

NEWTOWN SQUARE, Pa., April 21, 2017 /PRNewswire/ -- One of the world's prominent meetings in nephrology, the ISN World Congress of Nephrology is being held in Mexico City, Mexico from April 21st-25th (https://www.wcn2017.org/). Kibow has been participating at this bi-annual event since...



CSSi LifeSciences™ Executives Featured at Colorado BioScience Association BioBoot Camp 2017

Fri, 21 Apr 2017 15:00:00 EDT

(image) GLEN BURNIE, Md., April 21, 2017 /PRNewswire/ -- Today, Friday, April 21, 2017, members of CSSi LifeSciences™'s executive team served as featured speakers for BioBoot Camp 2017, a signature program produced by the Colorado BioScience Association (CBSA). Jim Sergi, President of CSSi...



Media Files:
https://mma.prnewswire.com/media/492758/CSSi_LifeSciences_Logo.jpg




BioMarin Receives Positive CHMP Opinion in Europe for Brineura™ (cerliponase alfa) for First Treatment of CLN2 Disease, a Form of Batten Disease and Ultra-Rare and Fatal Brain Disorder in Children

Fri, 21 Apr 2017 13:29:00 EDT

(image) SAN RAFAEL, Calif., April 21, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion for the company's...



Media Files:
http://www.bmrn.com




Intuitive Surgical Leads China Surgical Robotics Systems Market as New Competitors Enter the Market for Additional Applications

Fri, 21 Apr 2017 13:08:00 EDT

(image) VANCOUVER, British Columbia, April 21, 2017 /PRNewswire/ -- According to a new series of reports on the China surgical navigation and robotics systems market by iData Research (www.idataresearch.com), the market in China is currently dominated by Intuitive Surgical, but has seen the...



Media Files:
https://mma.prnewswire.com/media/492882/iData_Research_Logo.jpg




Mast Therapeutics Announces Adjournment Of Special Stockholders Meeting

Fri, 21 Apr 2017 13:00:00 EDT

(image) SAN DIEGO, April 21, 2017 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that the Special Meeting of Stockholders held earlier today was convened and adjourned without any business being conducted other than the adjournment.  The meeting will reconv...



Media Files:
https://mma.prnewswire.com/media/141787/mast_therapeutics__inc__logo.jpg




UCB showcases latest epilepsy research at 2017 Annual Meeting of the American Academy of Neurology

Fri, 21 Apr 2017 12:30:00 EDT

(image) ATLANTA, April 21, 2017 /PRNewswire/ -- UCB is pleased to announce that 12 scientific abstracts have been accepted for presentation at the upcoming Annual Meeting of the American Academy of Neurology (AAN) to be held April 22 to 28, 2017 in Boston, USA.1-12 Data being presented...



Media Files:
http://www.ucb.com




Global Biomarkers Technologies, Markets and Companies Report 2015-2017 & 2025 - Research and Markets

Fri, 21 Apr 2017 11:30:00 EDT

(image) DUBLIN, Apr. 21, 2017 /PRNewswire/ -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biomarkers - Technologies, Markets and Companies" to their offering. This report follows the broad definition of a biomarker as a characteristic that can be...



Media Files:
http://photos.prnewswire.com/prnvar/20160330/349511LOGO




CDI Laboratories and NeoBiotechnologies Form Alliance to Distribute CDI's 2500 Monospecific Transcription Factor Antibodies

Fri, 21 Apr 2017 11:00:00 EDT

MAYAGUEZ, Puerto Rico and BALTIMORE and UNION CITY, Calif., April 21, 2017 /PRNewswire/ -- CDI Laboratories (CDI) has granted exclusive worldwide distribution rights of its collection of over 2500 transcription factor monospecific monoclonal antibodies to NeoBiotechnologies. The...



New study with Philips Trilogy reveals payers and hospitals can save millions in readmission costs, hospitalization rates for COPD patients

Fri, 21 Apr 2017 10:48:00 EDT

(image) AMSTERDAM, April 21, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today announced results1 from a recent study showing significant decreases in both hospital and payer costs and hospitalization rates for severe chronic obstructive pulmonary disease (COPD)2 patients. The study...



Media Files:
https://mma.prnewswire.com/media/324348/royal_philips_logo.jpg




ATCC Opens Doors to New High-Tech Biorepository in Gaithersburg, MD

Fri, 21 Apr 2017 09:45:00 EDT

(image) MANASSAS, Va., April 21, 2017 /PRNewswire-USNewswire/ -- ATCC, a global leader in biological materials development, management and standards, is opening its new biorepository at 217 Perry Parkway in Gaithersburg, Md. Strategically located in the epicenter of Maryland's biotechnology...



Media Files:
https://mma.prnewswire.com/media/492780/ATCC_biorepository.jpg




NLS Pharma Announces Presentations at 6th World Congress on ADHD

Fri, 21 Apr 2017 09:00:00 EDT

(image) STANS, Switzerland, April 21, 2017 /PRNewswire/ -- (Booth #15) – NLS Pharma (NLS), a Swiss-based biotech group founded to develop first-in-class treatments for attention deficit hyperactivity disorder (ADHD) and other neurological disorders, today announced the following two presentations...



Media Files:
https://mma.prnewswire.com/media/490989/NLS_Pharma__Logo.jpg




ARMO BioSciences Announces Clinical Data Presentation for Immunotherapy AM0010 at the 12th European International Kidney Cancer Symposium

Fri, 21 Apr 2017 09:00:00 EDT

(image) REDWOOD CITY, Calif., April 21, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced that clinical data on the Company's lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) will be presented at the 12th European...



Media Files:
http://www.armobio.com




CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue Sarcomas at the 2017 American Society of Clinical Oncology Annual Meeting (ASCO)

Fri, 21 Apr 2017 09:00:00 EDT

(image) LOS ANGELES, April 21, 2017 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that an abstract describing results from its global Phase 3 clinical trial evaluating aldoxorubicin versus...



Media Files:
http://www.cytrx.com




DelMar Pharmaceuticals Announces Closing Of $9,000,000 Public Offering Of Common Stock And Warrants

Fri, 21 Apr 2017 08:30:00 EDT

(image) VANCOUVER, British Columbia and MENLO PARK, Calif., April 21, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has clo...



Media Files:
https://mma.prnewswire.com/media/483069/DelMar_Logo.jpg